lrmr-ex231_673.htm

EX-23.1 4 lrmr-ex231_673.htm EX-23.1 lrmr-ex231_673.htm

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-239510, 333-246370, and 333-228328) and Form S-8 (Nos. 333-239509 and 333-249287) of Larimar Therapeutics, Inc. of our report dated March 4, 2021 relating to the financial statements, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
March 4, 2021